1,521
Views
4
CrossRef citations to date
0
Altmetric
Articles

Autophagy mediates SUMO-induced degradation of a polyglutamine protein ataxin-3

&
Pages 169-176 | Received 13 Jan 2017, Accepted 30 Apr 2017, Published online: 25 May 2017

References

  • Arriagada G, Muntean LN, Goff SP. 2011. SUMO-interacting motifs of human TRIM5α are important for antiviral activity. PLoS Path. 7:e1002019. doi: 10.1371/journal.ppat.1002019
  • Bettermann K, Benesch M, Weis S, Haybaeck J. 2012. SUMOylation in carcinogenesis. Can Lett. 316:113–125. doi: 10.1016/j.canlet.2011.10.036
  • Cho SJ, Yun SM, Jo C, Lee DH, Choi KJ, Song JC, Park SI, Kim YJ, Koh YH. 2015. SUMO1 promotes Aβ production via the modulation of autophagy. Autophagy. 11:100–112. doi: 10.4161/15548627.2014.984283
  • Dorval V, Fraser PE. 2007. SUMO on the road to neurodegeneration. Biochim Biophys Acta. 1773:694–706. doi: 10.1016/j.bbamcr.2007.03.017
  • Durcan TM, Fon EA. 2013. Ataxin-3 and its E3 partners: implications for Machado–Jospeh disease. Front Neurol. 4:46. doi: 10.3389/fneur.2013.00046
  • Geoffroy MC, Jaffray EG, Walker KJ, Hay RT. 2010. Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies. Mol Biol Cell. 21:4227–4239. doi: 10.1091/mbc.E10-05-0449
  • Guo L, Giasson BI, Glavis-Bloom A, Brewer MD, Shorter J, Gitler AD, Yang X. 2014. A cellular system that degrades misfolded proteins and protects against neurodegeneration. Mol Cell. 55:15–30. doi: 10.1016/j.molcel.2014.04.030
  • Gupta MK, McLendon PM, Gulick J, James J, Khalili K, Robbins J. 2016. UBC9-mediated sumoylation favorably impacts cardiac function in compromised hearts. Circ Res. 118:1894–1905. doi: 10.1161/CIRCRESAHA.115.308268
  • Guzzo CM, Matunis MJ. 2013. Expanding SUMO and ubiquitin-mediated signaling through hybrid SUMO-ubiquitin chains and their receptors. Cell Cycle. 12:1015–1017. doi: 10.4161/cc.24332
  • Hecker CM, Rabiller M, Haglund K, Bayer P, Dikic I. 2006. Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem. 281:16117–16127. doi: 10.1074/jbc.M512757200
  • Hendriks IA, D’Souza RC, Yang B, Verlaan-de Vries M, Mann M, Vertegaal AC. 2014. Uncovering global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol. 21:927–936. doi: 10.1038/nsmb.2890
  • Her J, Jeong YY, Chung IK. 2015. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2. FEBS Lett. 589:3277–3286. doi: 10.1016/j.febslet.2015.09.030
  • Janer A, Werner A, Takahashi-Fujigasaki J, Daret A, Fujigasaki H, Takada K, Duyckaerts C, Brice A, Dejean A, Sittler A. 2010. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. Hum Mol Genet. 19:181–195. doi: 10.1093/hmg/ddp478
  • Jung NR, Lee DH. 2013. SUMO-1 promotes degradation of the polyglutamine disease protein ataxin-3. Anim Cells Sys. 17:7–14. doi: 10.1080/19768354.2012.738611
  • Liebelt F, Vertegaal AC. 2016. Ubiquitin-dependent and independent roles of SUMO in proteostasis. Am J Physiol Cell Physiol. 311:C284–C296. doi: 10.1152/ajpcell.00091.2016
  • Maroui MA, Kheddache-Atmane S, El Asmi F, Dianoux L, Aubry M, Chelbi-Alix MK. 2012. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms. PLoS One. 7:e44949. doi: 10.1371/journal.pone.0044949
  • Menzies FM, Huebener J, Renna M, Bonin M, Riess O, Rubinsztein DC. 2010. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain. 133:93–104. doi: 10.1093/brain/awp292
  • Naidu SR, Lakhter AJ, Androphy EJ. 2012. PIASγ-mediated Tip60 sumoylation regulates p53-induced autophagy. Cell Cycle. 11:2717–2728. doi: 10.4161/cc.21091
  • Nascimento-Ferreira I, Santos-Ferreira T, Sousa-Ferreira L, Auregan G, Onofre I, Alves S, Dufour N, Colomer Gould VF, Koeppen A, Déglon N, Pereira de Almeida L. 2011. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado–Joseph disease. Brain. 134:1400–1415. doi: 10.1093/brain/awr047
  • Ou Z, Luo M, Niu X, Chen Y, Xie Y, He W, Song B, Xian Y, Fan D, OuYang S, Sun X. 2016. Autophagy promoted the degradation of mutant ATXN3 in neurally differentiated spinocerebellar Ataxia-3 human induced pluripotent stem cells. Biomed Res Int. 2016:6701793. doi: 10.1155/2016/6701793
  • Ryu J, Cho S, Park BC, Lee DH. 2010. Oxidative stress-enhanced SUMOylation and aggregation of ataxin-1: implication of JNK pathway. Biochem Biophys Res Commun. 393:280–285. doi: 10.1016/j.bbrc.2010.01.122
  • Sarge KD, Park-Sarge OK. 2009. Sumoylation and human disease pathogenesis. Trends Biochem Sci. 34:200–205. doi: 10.1016/j.tibs.2009.01.004
  • Sriramachandran AM, Dohmen RJ. 2014. SUMO-targeted ubiquitin ligases. Biochim Biophys Acta. 1843:75–85. doi: 10.1016/j.bbamcr.2013.08.022
  • Su C-I, Tseng C-H, Yu C-Y, Lai MMC. 2016 SUMO modification stabilizes dengue virus nonstructural protein 5 to support virus replication. J Virol. 90:4308–4319. doi: 10.1128/JVI.00223-16
  • Todd TW, Lim J. 2013. Aggregate formation in the polyglutamine diseases: protection at a cost. Mol Cells. 36:185–194. doi: 10.1007/s10059-013-0167-x
  • Wani WY, Boyer-Guittaut M, Dodson M, Chatham J, Darley-Usmar V, Zhang J. 2015. Regulation of autophagy by protein post-translational modification. Lab Invest. 95:14–25. doi: 10.1038/labinvest.2014.131
  • Yang Y, Fiskus W, Yong B, Atadja P, Takahashi Y, Pandita TK, Wang HG, Bhalla KN. 2013. Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagy. Proc Natl Acad Sci USA. 110:6841–6846. doi: 10.1073/pnas.1217692110
  • Zhao Q, Xie Y, Zheng Y, Jiang S, Liu W, Mu W, Liu Z, Zhao Y, Xue Y, Ren J. 2014. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucl Acid Res. 42:W325–330. doi: 10.1093/nar/gku383
  • Zhou YF, Liao SS, Luo YY, Tang JG, Wang JL, Lei LF, Chi JW, Du J, Jiang H, Xia K, et al. 2013. SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity. PLoS One. 8:e54214. doi: 10.1371/journal.pone.0054214